Guide to Biotechnology Investing, published 5/27/11
Guide to Biotech Investing (Published in Investor Uprising in May 2011) This article is one year old but still relevant! Introduction: Balancing Portfolios With Biotech Rod Raynovich 5/27/2011 Recent breakthroughs with new drugs and devices have eclipsed many of the concerns of healthcare...
Biotechnology Stocks Continue To Rally After BIO Meeting in Boston
BioBuzz Rolls On After a bad day on NASDAQ yesterday with some profit taking in biotech there is a lot of green screen today. The sector is up 1% today and we are near all time highs like the XBI ($86.92). But to many investors, biotechnology is relatively unknown or still perceived as a...
Rayno Life Science Market Update: CELG, ONXX, XBI Update 1
Sell-off gets worse with S&P down 2%. Moody's downgrade of banks expected by end of day. Bear market for commodities? ----------- We have been at BIO 2012 in Boston over the past week and will provide interesting trends and data from the Meeting by Monday. Global Slowdown Fears: Market off...
ASCO Week News Summaries
Here are some other good ASCO News sources from MedAdNews: PharmAviary provides a round up of the industry tweets of the week. Chris Truelove, editor in chief of Med Ad News and R&D Directions, scours the healthcare blogosphere to bring you a digestible summary of the big trends and issues...
Very Limited ASCO Boost For Biotechnology Stocks – Update 1 PCYC
A Biopharma Stock We Missed-Pharmacyclics (PCYC $38.21) up 9.89% today It is unbelievable that we missed the huge move in PCYC up 157% YTD with a one year range of 7.63 to 38.56. The market cap is $2.63B. The Company has a robust pipeline of products led by Ibrutinib, a Bruton tyrosine kinase...